Capital Fund Management (CFM)
AGIO icon

Capital Fund Management (CFM)’s Agios Pharmaceuticals AGIO Stock Holding History

Capital Fund Management (CFM)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Sell
104,080
-25,451
-20% -$772K 0.02% 1053
2026
Q1 		$4.38M Buy
129,531
+93,743
+262% +$2.66M 0.02% 952
2025
Q4 		$974K Buy
+35,788
New +$1.26M ﹤0.01% 2034
2025
Q3 		– Sell
-68,502
Closed -$2.28M – 2414
2025
Q2 		$2.28M Sell
68,502
-3,800
-5% -$115K 0.01% 1600
2025
Q1 		$2.12M Buy
+72,302
New +$2.4M 0.01% 1402
2023
Q3 		– Sell
-41,455
Closed -$1.17M – 1905
2023
Q2 		$1.17M Buy
41,455
+10,736
+35% +$267K ﹤0.01% 1359
2023
Q1 		$706K Sell
30,719
-21,597
-41% -$574K ﹤0.01% 1373
2022
Q4 		$1.47M Buy
52,316
+39,042
+294% +$1.1M 0.01% 1030
2022
Q3 		$375K Buy
+13,274
New +$356K ﹤0.01% 1321
2020
Q4 		– Sell
-34,234
Closed -$1.2M – 1263
2020
Q3 		$1.2M Buy
34,234
+20,293
+146% +$889K 0.01% 823
2020
Q2 		$746K Buy
+13,941
New +$646K 0.01% 788
2020
Q1 		– Sell
-17,705
Closed -$818K – 1521
2019
Q4 		$845K Buy
17,705
+1,331
+8% +$50.3K 0.01% 1156
2019
Q3 		$531K Buy
+16,374
New +$678K ﹤0.01% 1234
2017
Q2 		– Sell
-88,185
Closed -$5.15M – 1435
2017
Q1 		$5.15M Buy
+88,185
New +$4.23M 0.04% 461
2016
Q4 		– Sell
-95,510
Closed -$5.04M – 1613
2016
Q3 		$5.04M Buy
95,510
+65,663
+220% +$2.86M 0.05% 461
2016
Q2 		$1.25M Buy
+29,847
New +$1.47M 0.01% 885
2015
Q4 		– Sell
-101,299
Closed -$7.15M – 1515
2015
Q3 		$7.15M Buy
101,299
+80,888
+396% +$7.91M 0.08% 305
2015
Q2 		$2.27M Buy
+20,411
New +$2.2M 0.03% 590

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Capital Fund Management (CFM)'s AGIO Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Agios Pharmaceuticals (AGIO) stake by 20% in Q2 2026, selling an estimated $772K and leaving 104,080 shares worth $3.86M. The position accounts for 0.02% of the portfolio, ranked #1053.

Capital Fund Management (CFM) first reported a position in AGIO in Q2 2015 and has held it in 18 quarters since. The position peaked at $7.15M in Q3 2015. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Capital Fund Management (CFM) held 104,080 shares of Agios Pharmaceuticals worth $3.86M as of Q2 2026.
  • Capital Fund Management (CFM) sold 25,451 Agios Pharmaceuticals shares in Q2 2026, an estimated $772K.
  • Agios Pharmaceuticals made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1053 holding.
  • Capital Fund Management (CFM) first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 18 quarters since.
  • Capital Fund Management (CFM)'s Agios Pharmaceuticals position peaked at $7.15M in Q3 2015.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.